203 related articles for article (PubMed ID: 21876843)
1. Current concepts on dedifferentiation/high-grade transformation in salivary gland tumors.
Costa AF; Altemani A; Hermsen M
Patholog Res Int; 2011; 2011():325965. PubMed ID: 21876843
[TBL] [Abstract][Full Text] [Related]
2. "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.
Nagao T
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S37-47. PubMed ID: 23821210
[TBL] [Abstract][Full Text] [Related]
3. High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance.
Skalova A; Leivo I; Hellquist H; Agaimy A; Simpson RHW; Stenman G; Vander Poorten V; Bishop JA; Franchi A; Hernandez-Prera JC; Slouka D; Willems SM; Olsen KD; Ferlito A
Adv Anat Pathol; 2021 May; 28(3):107-118. PubMed ID: 33825717
[TBL] [Abstract][Full Text] [Related]
4. High-grade transformation/dedifferentiation of an adenoid cystic carcinoma of the minor salivary gland to myoepithelial carcinoma.
Tando S; Nagao T; Kayano K; Fushiki S; Itoh K
Pathol Int; 2018 Feb; 68(2):133-138. PubMed ID: 29287310
[TBL] [Abstract][Full Text] [Related]
5. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma.
Simpson RH; Pereira EM; Ribeiro AC; Abdulkadir A; Reis-Filho JS
Histopathology; 2002 Sep; 41(3):250-9. PubMed ID: 12207787
[TBL] [Abstract][Full Text] [Related]
6. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
8. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
10. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan and CD44 expression in minor salivary gland tumors.
Xing R; Regezi JA; Stern M; Shuster S; Stern R
Oral Dis; 1998 Dec; 4(4):241-7. PubMed ID: 10200702
[TBL] [Abstract][Full Text] [Related]
13. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature.
Seethala RR; Hunt JL; Baloch ZW; Livolsi VA; Leon Barnes E
Am J Surg Pathol; 2007 Nov; 31(11):1683-94. PubMed ID: 18059225
[TBL] [Abstract][Full Text] [Related]
14. Case study of a parotid gland adenocarcinoma dedifferentiated from epithelial-myoepithelial carcinoma.
Aydın S; Taskin U; Ozdamar K; Yücebas K; Sar M; Oktay MF; Tetikkurt US
Case Rep Otolaryngol; 2014; 2014():629054. PubMed ID: 25276459
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
Rotellini M; Palomba A; Baroni G; Franchi A
Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
[TBL] [Abstract][Full Text] [Related]
16. Maspin and MCM2 immunoprofiling in salivary gland carcinomas.
Ghazy SE; Helmy IM; Baghdadi HM
Diagn Pathol; 2011 Sep; 6():89. PubMed ID: 21943228
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
Foschini MP; Krausz T
Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
[TBL] [Abstract][Full Text] [Related]
18. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
19. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
20. Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis.
Akrish S; Peled M; Ben-Izhak O; Nagler RM
Oral Oncol; 2009 Dec; 45(12):1044-50. PubMed ID: 19729335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]